Compass Pathways Plc (CMPS) Stock Analysis

Sector: HEALTHCARE - MEDICAL CARE FACILITIES

Exchange: NASDAQ

Key Metrics

• Price: $7.33
• Market Cap: $767.18M
• EPS: $-2.72
• 52-Week High: $8.90
• 52-Week Low: $2.25

Market Sentiment

Compass Pathways Plc currently has a Bullish sentiment score of 0.27.

About Compass Pathways Plc

Compass Pathways plc is a leading mental health care company dedicated to innovating treatments for mental health conditions through the development of psychedelic therapies, particularly psilocybin. Based in Cheshire, UK, and active in both the UK and US markets, the company is at the forefront of clinical research aimed at addressing significant unmet needs in mental health care, notably for treatment-resistant depression. With a robust commitment to research and development, Compass Pathwa...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Compass Pathways Plc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CMPS pay dividends?

Compass Pathways Plc (CMPS) does not currently pay a regular dividend.

What is CMPS's market cap?

Compass Pathways Plc (CMPS) has a market capitalization of $767.18M with a current stock price of $7.33.